🎒 APAC Secondary Enrollments. 38% Chemical Water Waste. Vaccination Coverage.
Chart of the Day #113 looks at School Enrollment, Chemical Waste Water and Vaccination rates.
QS
🐪 Saudi Arabia Stock Index Up 3%. $470M+ VC Funding.
Impact Capital Markets #115 looks at our Saudi Arabian Stock Index, major impact deals, M&A, and upcoming economic releases.
♻️ 13Y Free Education. 3.7M Ton Recycled Waste. Chronic Kidney Disease.
Chart of the Day #115 looks at Free Education, Recycling and Chronic Kidney Disease.
🌳 520,000 km² Forest Cover Lost in Brazil. China Renewable Capacity. School Closures.
Chart of the Day #114 looks at School Closures, Renewable Capacity and Deforestation.
🏯 Vietnam Index Up 8%. $255M+ VC Funding.
Impact Capital Markets #114 looks at our Vietnam Stock Index, major impact deals, M&A, and upcoming economic releases.
🌮 Mexico Stock Index Down 4%. $1B+ VC Funding Day.
Impact Capital Markets #113 looks at our Mexico Stock Index, major impact deals, M&A, and upcoming economic releases.
🏫 University Closures + HolonIQ's Upcoming Summits
Between 1969 and 2021, 1,363 degree-granting postsecondary institutions in the United States closed. Join HolonIQ in 🇫🇷 Paris and 🇺🇸 New York City.
🏞️ Nigeria Stock Index Down 41%. $105M+ VC Funding.
Impact Capital Markets #112 looks at our Nigeria Stock Index, major impact deals, M&A, and upcoming economic releases.
💵 +50% Student Debt. Energy Consumption. Food Waste Emissions.
Chart of the Day #112 looks at US Student Debt, Energy Consumption and Food Waste.
🚢 Ports Index Grows 15%. $215M+ VC Funding.
Impact Capital Markets #111 looks at our Ports Stock Index, major impact deals, M&A, and upcoming economic releases.
💨 Rising Japan Air Pollution. Language App Downloads. 30% Obesity Rates.
Chart of the Day #111 looks at Language Learning, Air Pollution, and Obesity Rates.
🍚 Nutrition and Supplement Regulations + Africa Health Tech 50
Governments are tightening regulations surrounding nutrition and supplements and are seeking means to improve enforcement efficiencies, evidenced by the upcoming US FDA reorganization.